SCHEMBL3790388

SCHEMBL3790388

C#CCCCOS(=O)(=O)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.41
CA9 Q16790 1/20 0.41
CA1 P00915 1/20 0.37
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3788536 0.94 CA2 (0.39) CA2CA9CA1CYP1A2CYP2D6
SCHEMBL23150453 0.92 CA2 (0.38) CA2CA9CA1CYP1A2CYP2D6
SCHEMBL3785941 0.88 CA2 (0.54) CA2CA9CA1
SCHEMBL575713 0.80 CA2 (0.44) CA2CA9CA1
SCHEMBL576009 0.80 CA2 (0.44) CA2CA9CA1
SCHEMBL4952312 0.78 CA2 (0.46) CA2CA9CA1
SCHEMBL2735589 0.78 CA2 (0.46) CA2CA9CA1
SCHEMBL23291930 0.78 CA2 (0.46) CA2CA9CA1
SCHEMBL14779178 0.78 CA2 (0.46) CA2CA9CA1
SCHEMBL8398329 0.78 CA2 (0.46) CA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4072530-B1 STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY CENTRE NAT RECH SCIENT (FR) 2023-08-30 EP disclosed
EP-4072530-B1 STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY CENTRE NAT RECH SCIENT (FR) 2023-08-30 EP disclosed
US-20230093684-A1 STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-03-23 US disclosed
EP-4072530-A1 STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY Centre national de la recherche scientifique (FR) 2022-10-19 EP disclosed
WO-2021116331-A1 STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-06-17 WO disclosed
WO-2021116331-A1 STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-06-17 WO disclosed
US-20200157138-A1 NICOTINAMIDE ADENINE DINUCLEOTIDE ANALOGUES UNIVERSITY OF SOUTHERN CALIFORNIA 2020-05-21 US disclosed
WO-2010118711-A2 NOVEL HELQUATS, THEIR PRECURSORS AND METHOD OF PREPARATION THEREOF Ústav organické chemie a biochemie Akademie ved Ceské republiky, v.v.i. (CZ) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157138-A1 NICOTINAMIDE ADENINE DINUCLEOTIDE ANALOGUES NAMPT, NNT, NNMT CA2 4500/4885CA9 3618/4885CA1 4603/4885
US-20230093684-A1 STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY PPIA, PPIB, CYBA CA2 2608/4885CA9 2887/4885CA1 3812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.